Gidon Berger

767 total citations
40 papers, 535 citations indexed

About

Gidon Berger is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Infectious Diseases. According to data from OpenAlex, Gidon Berger has authored 40 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 9 papers in Cardiology and Cardiovascular Medicine and 6 papers in Infectious Diseases. Recurrent topics in Gidon Berger's work include Heart Failure Treatment and Management (4 papers), Ion Transport and Channel Regulation (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Gidon Berger is often cited by papers focused on Heart Failure Treatment and Management (4 papers), Ion Transport and Channel Regulation (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Gidon Berger collaborates with scholars based in Israel, United States and Germany. Gidon Berger's co-authors include Zaher S. Azzam, Mordechai Yigla, Arie Oksenberg, Rachel P. Berger, Emília Hardak, Hannah Sprecher, Ilana Oren, Danny Epstein, Tanya Mashiach and Ron Hoffman and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Pain.

In The Last Decade

Gidon Berger

38 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gidon Berger Israel	13	164	119	115	110	64	40	535
Sammy C. Campbell United States	12	343 2.1×	116 1.0×	136 1.2×	38 0.3×	29 0.5×	35	530
Rongchang Chen China	18	577 3.5×	106 0.9×	205 1.8×	37 0.3×	82 1.3×	63	823
Kaixiong Liu China	13	185 1.1×	137 1.2×	97 0.8×	34 0.3×	199 3.1×	25	574
Najmul Islam Pakistan	16	48 0.3×	86 0.7×	58 0.5×	38 0.3×	42 0.7×	73	774
Joel Zonszein United States	13	41 0.3×	96 0.8×	261 2.3×	67 0.6×	111 1.7×	32	974
Christina W. Agudelo United States	9	165 1.0×	83 0.7×	77 0.7×	48 0.4×	80 1.3×	24	600
M Dottorini Italy	15	206 1.3×	175 1.5×	197 1.7×	69 0.6×	34 0.5×	33	620
P Maruna Czechia	12	99 0.6×	312 2.6×	90 0.8×	104 0.9×	49 0.8×	48	672
Mei‐Chen Yang Taiwan	15	320 2.0×	72 0.6×	229 2.0×	74 0.7×	49 0.8×	74	710

Countries citing papers authored by Gidon Berger

Since Specialization

Citations

This map shows the geographic impact of Gidon Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gidon Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gidon Berger more than expected).

Fields of papers citing papers by Gidon Berger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gidon Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gidon Berger. The network helps show where Gidon Berger may publish in the future.

Co-authorship network of co-authors of Gidon Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Gidon Berger. A scholar is included among the top collaborators of Gidon Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gidon Berger. Gidon Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Braun, Eyal, Netanel A. Horowitz, Ronit Leiba, et al.. (2022). Association between IgG antibody levels and adverse events after first and second Bnt162b2 mRNA vaccine doses. Clinical Microbiology and Infection. 28(12). 1644–1648. 6 indexed citations

Kinaneh, Safa, et al.. (2021). Identification, localization and expression of NHE isoforms in the alveolar epithelial cells. PLoS ONE. 16(4). e0239240–e0239240. 7 indexed citations

Berger, Gidon, Netanel A. Horowitz, Yael Shachor‐Meyouhas, et al.. (2021). Hospital solution for COVID-19 isolation facility. American Journal of Disaster Medicine. 16(1). 35–41. 2 indexed citations

Berger, Gidon, et al.. (2021). Career Trajectory of Physicians Following a Fellowship Program: A Descriptive Study. Rambam Maimonides Medical Journal. 12(2). e0011–e0011. 2 indexed citations

Korach-Rechtman, Hila, et al.. (2020). Intestinal Dysbiosis in Carriers of Carbapenem-Resistant Enterobacteriaceae. mSphere. 5(2). 26 indexed citations

Berger, Gidon, et al.. (2020). Delayed discharges from a tertiary teaching hospital in Israel- incidence, implications, and solutions. Israel Journal of Health Policy Research. 9(1). 66–66. 1 indexed citations

Berger, Gidon, Khetam Hussein, Shimon A. Reisner, et al.. (2020). Israeli underground hospital conversion for treating COVID-19 patients. American Journal of Disaster Medicine. 15(3). 159–167. 7 indexed citations

Epstein, Danny, Gidon Berger, Noam Barda, et al.. (2018). The incidence of acute pulmonary embolism following syncope in anticoagulant-naïve patients: A retrospective cohort study. PLoS ONE. 13(3). e0193725–e0193725. 2 indexed citations

Giryes, Sami, et al.. (2017). Severe Coagulation Disorder and Thrombocytopenia Associated with Tigecycline – Case Report and Review of Literature. Current Drug Safety. 12(1). 7–9. 14 indexed citations

10.

Guetta, Julia, et al.. (2015). The Role of Angiotensin II and Cyclic AMP in Alveolar Active Sodium Transport. PLoS ONE. 10(7). e0134175–e0134175. 11 indexed citations

11.

Berger, Gidon, Roni Bitterman, & Zaher S. Azzam. (2015). The Human Microbiota: The Rise of an "Empire". SHILAP Revista de lepidopterología. 6(2). e0018–e0018. 12 indexed citations

12.

Berger, Gidon & Richard G. Wunderink. (2013). Lung microbiota: genuine or artifact?. PubMed. 15(12). 731–3. 10 indexed citations

13.

Guetta, Julia, Gidon Berger, Bishara Bishara, et al.. (2012). Vasopressin-2 Receptor Antagonist Attenuates the Ability of the Lungs to Clear Edema in an Experimental Model. American Journal of Respiratory Cell and Molecular Biology. 47(5). 583–588. 5 indexed citations

14.

Berger, Gidon, et al.. (2011). Preliminary prospective explanatory observation on the impact of 3-month steroid therapy on the objective measures of sleep-disordered breathing. Sleep And Breathing. 16(2). 549–553. 13 indexed citations

15.

Hardak, Emília, Mordechai Yigla, Gidon Berger, Hannah Sprecher, & Ilana Oren. (2011). Clinical Spectrum and Outcome of Nocardia Infection: Experience of 15-Year Period From a Single Tertiary Medical Center. The American Journal of the Medical Sciences. 343(4). 286–290. 50 indexed citations

16.

Hardak, Emília, Gidon Berger, Norberto Krivoy, Anna Solomonov, & Mordechai Yigla. (2010). Nitrofurantoin Pulmonary Toxicity: Neglected Threat. Current Drug Safety. 5(2). 125–128. 4 indexed citations

17.

Braun, Eyal, et al.. (2009). Adherence to guidelines improves the clinical outcome of patients with acutely decompensated heart failure.. PubMed. 11(6). 348–53. 11 indexed citations

18.

Berger, Gidon, Rachel P. Berger, & Arie Oksenberg. (2008). Progression of snoring and obstructive sleep apnoea: the role of increasing weight and time. European Respiratory Journal. 33(2). 338–345. 73 indexed citations

19.

Granot, Michal, Gidon Berger, Norberto Krivoy, et al.. (2007). Clinical and experimental pain perception is attenuated in patients with painless myocardial infarction ☆,☆☆. Pain. 133(1). 120–127. 19 indexed citations

20.

Rupprecht, E, et al.. (1977). [Unilateral aplasia and hypoplasia of pulmonary artery in childhood (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 147(1). 57–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact